Redasoft, Worley Sign
Distribution Agreement for Visual Cloning Software in Australia.
Toronto, ON - October 23, 2002
- Redasoft, a global provider of drug discovery productivity enhancement
software for the life science research community and Worley, a leading
distributor of chemistry and biological software, today announced an
agreement for the non-exclusive distribution of Redasoft’s desktop
software product, Visual Cloning, for the Australian market.
"The Australian biotechnology industry consists of 650 firms of
which 60 are publicly listed on the Australian Stock Exchange (ASX),"
said Danny Reda, Redasoft’s President and Chief Executive Officer.
"These companies employ 6,000 people, have generated more than $800
million in revenues, and currently have over 150 products in clinical or
field trials. In addition, the Australian government has implemented
policy and support programs to stimulate and develop biotechnology
investment. We are therefore pleased to have Worley as our distribution
partner for the Australian market."
Redasoft Visual Cloning is an industry leading software suite that
enables increased efficiency and productivity in drug discovery
research. Key features of the software include exceptional graphics,
extensive web integration, advanced restriction analysis, open reading
frames search, primer design, a sequence viewer, subsequence search, and
an intuitive user interface.
About Worley Advanced Analysis
Part of the Worley Group of Companies, the
Worley Advanced Analysis Group (WAAG) has been marketing and supporting
software for the life science and engineering communities in Australia
for 12 years. With a strong customer focus, WAAG add value by offering
complementary user training, consultancy and software customisation
services using a team of scientists, engineers and IT specialists. WAAG
has the backing of the parent Worley organisation, an international
engineering contractor with 4000 employees, operating in Australia,
Asia, the US and the Middle East. For more information on Worley, visit http://www.worley.com.au.
About Redasoft
Based in Toronto, Canada, Redasoft is a global provider of drug discovery productivity enhancement software for the life science research community. Founded in 1997, Redasoft’s mission is to be an enabling solutions provider of intuitive, easy to use integrating software and services for drug discovery research. Redasoft's software empowers life science researchers to visualize genetic data, analyze biomolecules, and develop experiment strategies to learn more about the fundamental building blocks of life. Additional information about Redasoft can be found at http://www.redasoft.com.
Redasoft and the Redasoft logo are trademarks of Redasoft Corporation. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.
Note to editors: If you are interested in viewing additional information on Redasoft, please visit the Redasoft Web page at
http://www.redasoft.com/corporate/
on Redasoft's corporate information pages.
Contact
For further information, contact Evan Carmichael at ecarmichael@redasoft.com
.
